Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Marais

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Human Gene Therapy|February 19, 2000
Regressions of established breast carcinoma xenografts by carboxypeptidase G2 suicide gene therapy and the prodrug CMDA are due to a bystander effectS M Stribbling, F Friedlos, J Martin, et al.
Journal of Medicinal Chemistry|April 30, 2004
Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systemsI Niculescu-Duvaz, I Scanlon, D Niculescu-Duvaz, et al.
Molecular and Cellular Biology|February 7, 2001
Regulation of mitogen-activated protein kinases in cardiac myocytes through the small G protein Rac1A Clerk, F H Pham, S J Fuller, et al.
Journal of Medicinal Chemistry|December 19, 1998
Self-immolative nitrogen mustard prodrugs for suicide gene therapyD Niculescu-Duvaz, I Niculescu-Duvaz, F Friedlos, et al.
The EMBO Journal|April 11, 2001
MEK kinase activity is not necessary for Raf-1 functionM Hüser, J Luckett, A Chiloeches, et al.
Molecular and Cellular Biology|October 5, 2001
Calmodulin binds to K-Ras, but not to H- or N-Ras, and modulates its downstream signalingP Villalonga, C López-Alcalá, M Bosch, et al.
The Journal of Biological Chemistry|August 25, 1992
Localization of O-GlcNAc modification on the serum response transcription factorA J Reason, H R Morris, M Panico, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibitionS Turajlic, S J Furney, G Stamp, et al.
British Journal of Cancer|August 2, 2006
Cellular senescence in naevi and immortalisation in melanoma: a role for p16?V C Gray-Schopfer, S C Cheong, H Chong, et al.
European Journal of Cancer (Oxford, England : 1990)|November 28, 2017
Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patientsS Valpione, G Gremel, P Mundra, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Human Gene Therapy|February 19, 2000
Regressions of established breast carcinoma xenografts by carboxypeptidase G2 suicide gene therapy and the prodrug CMDA are due to a bystander effectS M Stribbling, F Friedlos, J Martin, et al.
Journal of Medicinal Chemistry|April 30, 2004
Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systemsI Niculescu-Duvaz, I Scanlon, D Niculescu-Duvaz, et al.
Molecular and Cellular Biology|February 7, 2001
Regulation of mitogen-activated protein kinases in cardiac myocytes through the small G protein Rac1A Clerk, F H Pham, S J Fuller, et al.
Journal of Medicinal Chemistry|December 19, 1998
Self-immolative nitrogen mustard prodrugs for suicide gene therapyD Niculescu-Duvaz, I Niculescu-Duvaz, F Friedlos, et al.
The EMBO Journal|April 11, 2001
MEK kinase activity is not necessary for Raf-1 functionM Hüser, J Luckett, A Chiloeches, et al.
Molecular and Cellular Biology|October 5, 2001
Calmodulin binds to K-Ras, but not to H- or N-Ras, and modulates its downstream signalingP Villalonga, C López-Alcalá, M Bosch, et al.
The Journal of Biological Chemistry|August 25, 1992
Localization of O-GlcNAc modification on the serum response transcription factorA J Reason, H R Morris, M Panico, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibitionS Turajlic, S J Furney, G Stamp, et al.
British Journal of Cancer|August 2, 2006
Cellular senescence in naevi and immortalisation in melanoma: a role for p16?V C Gray-Schopfer, S C Cheong, H Chong, et al.
European Journal of Cancer (Oxford, England : 1990)|November 28, 2017
Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patientsS Valpione, G Gremel, P Mundra, et al.
Pageof 7